Auro Laboratories Ltd Quarterly Result
Auro Laboratories Ltd
NSE: AUROLABS
Net Profit - Last Quarter
Auro Laboratories Ltd Quarterly Results Key Highlights
- The revenue of Auro Laboratories Ltd for the Sep '25 is ₹ 9.81 crore as compare to the Jun '25 revenue of ₹ 3.19 crore.
- This represent the growth of 207.52% The ebitda of Auro Laboratories Ltd for the Sep '25 is ₹ 3.33 crore as compare to the Jun '25 ebitda of ₹ 0.45 crore.
- This represent the growth of 640% The net profit of Auro Laboratories Ltd for the Sep '25 is ₹ 0.72 crore as compare to the Jun '25 net profit of ₹ -0.11 crore.
- This represent the decline of -754%.
Auro Laboratories Ltd Quarterly Results Analysis
Market Price of Auro Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 29 Jul 2026 | 235 |
| 28 Jul 2026 | 237 |
| 27 Jul 2026 | 240 |
| 24 Jul 2026 | 243.9 |
| 23 Jul 2026 | 240.5 |
| 22 Jul 2026 | 243.1 |
| 21 Jul 2026 | 241.8 |
| 20 Jul 2026 | 241.75 |
| 17 Jul 2026 | 241.95 |
| 16 Jul 2026 | 237.1 |
Historical Revenue of Auro Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Auro Laboratories Ltd
Historical EBITDA of Auro Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Auro Laboratories Ltd
Historical Net Profit of Auro Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Auro Laboratories Ltd
Auro Laboratories Ltd News Hub
Auro Laboratories standalone net profit rises 5.63% in the June 2024 quarter
Net profit of Auro Laboratories rose 5.63% to Rs 0.75 crore in the quarter ended June 2024 as agains
Read more
10 Aug 24
Auro Laboratories to announce Quarterly Result
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 August 2024 Powe
Read more
01 Aug 24
Auro Laboratories to hold board meeting
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024 P
Read more
06 Nov 24
Auro Laboratories standalone net profit declines 81.73% in the September 2024 quarter
Net profit of Auro Laboratories declined 81.73% to Rs 0.36 crore in the quarter ended September 2024
Read more
12 Nov 24
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Auro Laboratories Ltd
- Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
- Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
- The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
- The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
- Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.
FAQs for Quarterly Results of Auro Laboratories Ltd
What key financial metrics are included in Auro Laboratories Ltd's quarterly results?
When does Auro Laboratories Ltd announce its quarterly results?
How does Auro Laboratories Ltd's quarterly performance impact its stock price?
What is the impact of Auro Laboratories Ltd's quarterly results on dividends?
Are there any special announcements usually made during Auro Laboratories Ltd's quarterly results?
